<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03457363</url>
  </required_header>
  <id_info>
    <org_study_id>Duprezbruyneel</org_study_id>
    <nct_id>NCT03457363</nct_id>
  </id_info>
  <brief_title>Double Trunk Mask and Standard Nasal Cannula During Acute Hypoxia</brief_title>
  <official_title>Effect of the Adjunction of the Double Trunk Mask Above Standard Nasal Cannula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratory of Movement, Condorcet, Tournai, Belgium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratory of Movement, Condorcet, Tournai, Belgium</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to determine whether adjunctive mask of our design (Double
      Trunk Mask - DTM) has an effect on increasing arterial pressure in Oxygen (PaO2) diagnosed
      with severe hypoxia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-center, randomized, blind investigator, 2-way crossover study design.
      Enrolled participants had hypoxia being treated at Intensive Care Unit associated with a
      hospital in Hornu (Epicura).

      The study consisted of two intervention periods separated by a washout period of 30 minutes.

      The objective of the study is to determine whether adjunctive mask of our design (Double
      Trunk Mask - DTM) has an effect on increasing arterial pressure in Oxygen (PaO2) diagnosed
      with hypoxia.

      The protocol and informed consent documents were reviewed and approved by a recognized ethics
      review board at the study facility. The study was performed in accordance with the
      Declaration of Helsinki.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 20, 2018</start_date>
  <completion_date type="Actual">November 20, 2018</completion_date>
  <primary_completion_date type="Actual">July 20, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Comparison of level oxygenation between classical oxygenation with nasal canulae with or without adjunctive of a double trunk mask</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygenation</measure>
    <time_frame>30 minutes</time_frame>
    <description>we will observe effect of adjunction of a DTM on PaO2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PaCO2</measure>
    <time_frame>30 minutes</time_frame>
    <description>we will observe the effect of the addition of the DTM on PaCO2</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Hypoxia</condition>
  <arm_group>
    <arm_group_label>Double Trunk Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DTM will be add above nasal cannula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nasal Cannula Alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive oxygen only thought nasal Cannula</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DTM will be add above NC</intervention_name>
    <description>After oxygenation by classical nasal cannula, the DTM will be place above NC</description>
    <arm_group_label>Double Trunk Mask</arm_group_label>
    <arm_group_label>Nasal Cannula Alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Regardless of gender, at least 18 years of age and diagnosed with Hypoxia (PaO2/FiO2 &lt;
             380 mm Hg), dyspnea, respiratory rate (RR) ≥ 25 CPM, PaCO2 ≤ 45 mmHg, patient with an
             arterial catheter and without hemodynamic instability, Glasgow Coma Scale ≥ 12/15,
             written consent. Participants were also required to have a sufficient level of
             education to understand study procedures and be able to communicate with site
             personnel.

        Exclusion Criteria:

          -  Patients were excluded if they Hypercapnia (&gt; 45 mm Hg with respiratory acidosis),
             COPD, pulmonary fibrosis, hypoventilation obesity syndrome, arterial pressure &lt; 60 mm
             Hg or treatment by epinephrine &gt; to 0,1 gamma/kg/minute, deterioration of awareness
             (Glasgow scale &lt; or = 12), acute confusional state.

        Participants were randomized in a 1:1 ratio to receive either classical oxygenation with
        nasal cannula (NC) for 20 minutes or NC with an adjunctive of a Double Trunk Mask.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Epicura</name>
      <address>
        <city>Hornu</city>
        <state>Hainaut</state>
        <zip>7301</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Oude Nijhuis JC, Haane DY, Koehler PJ. A review of the current and potential oxygen delivery systems and techniques utilized in cluster headache attacks. Cephalalgia. 2016 Sep;36(10):970-9. doi: 10.1177/0333102415616878. Epub 2015 Nov 12. Review.</citation>
    <PMID>26566938</PMID>
  </reference>
  <reference>
    <citation>Wettstein RB, Shelledy DC, Peters JI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care. 2005 May;50(5):604-9.</citation>
    <PMID>15871753</PMID>
  </reference>
  <reference>
    <citation>Tiep BL, Nicotra B, Carter R, Belman MJ, Mittman C. Evaluation of a low-flow oxygen-conserving nasal cannula. Am Rev Respir Dis. 1984 Sep;130(3):500-2.</citation>
    <PMID>6476597</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>February 24, 2018</study_first_submitted>
  <study_first_submitted_qc>March 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2018</study_first_posted>
  <last_update_submitted>July 22, 2019</last_update_submitted>
  <last_update_submitted_qc>July 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laboratory of Movement, Condorcet, Tournai, Belgium</investigator_affiliation>
    <investigator_full_name>frédéric Duprez</investigator_full_name>
    <investigator_title>EPICURA ICU Hornu</investigator_title>
  </responsible_party>
  <keyword>oxygen</keyword>
  <keyword>nasal cannula</keyword>
  <keyword>double trunk mask</keyword>
  <keyword>hypoxia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 5, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT03457363/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 5, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT03457363/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 5, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT03457363/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

